DE69841037D1 - Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung. - Google Patents
Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung.Info
- Publication number
- DE69841037D1 DE69841037D1 DE69841037T DE69841037T DE69841037D1 DE 69841037 D1 DE69841037 D1 DE 69841037D1 DE 69841037 T DE69841037 T DE 69841037T DE 69841037 T DE69841037 T DE 69841037T DE 69841037 D1 DE69841037 D1 DE 69841037D1
- Authority
- DE
- Germany
- Prior art keywords
- proteins
- nucleic acid
- polypeptides
- antibodies
- acid molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 3
- 241000605314 Ehrlichia Species 0.000 title abstract 2
- 238000012512 characterization method Methods 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 8
- 150000007523 nucleic acids Chemical class 0.000 abstract 7
- 108090000623 proteins and genes Proteins 0.000 abstract 7
- 108020004707 nucleic acids Proteins 0.000 abstract 6
- 102000039446 nucleic acids Human genes 0.000 abstract 6
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 108020004711 Nucleic Acid Probes Proteins 0.000 abstract 2
- 208000000292 ehrlichiosis Diseases 0.000 abstract 2
- 239000002853 nucleic acid probe Substances 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 108091005461 Nucleic proteins Proteins 0.000 abstract 1
- 238000004166 bioassay Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 210000004408 hybridoma Anatomy 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4493397P | 1997-04-25 | 1997-04-25 | |
| PCT/US1998/008265 WO1998049313A2 (en) | 1997-04-25 | 1998-04-24 | Characterization of granulocytic ehrlichia and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69841037D1 true DE69841037D1 (de) | 2009-09-17 |
Family
ID=21935120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69841037T Expired - Lifetime DE69841037D1 (de) | 1997-04-25 | 1998-04-24 | Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung. |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US6204252B1 (de) |
| EP (3) | EP2060631A3 (de) |
| AT (1) | ATE438657T1 (de) |
| AU (1) | AU7256398A (de) |
| CA (1) | CA2258277C (de) |
| DE (1) | DE69841037D1 (de) |
| ES (1) | ES2330393T3 (de) |
| WO (1) | WO1998049313A2 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6277381B1 (en) * | 1997-03-21 | 2001-08-21 | Corixa Corporation | Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| US6207169B1 (en) | 1997-03-21 | 2001-03-27 | Corixa Corporation | Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| US6231869B1 (en) | 1997-03-21 | 2001-05-15 | Corixa Corporation | Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| US6673356B1 (en) | 1997-03-21 | 2004-01-06 | Corixa Corporation | Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| ATE438657T1 (de) * | 1997-04-25 | 2009-08-15 | Antigenics Inc | Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung. |
| JP2002527042A (ja) * | 1998-07-28 | 2002-08-27 | アクウィラ・バイオファーマシューティカルズ・インコーポレイテッド | 顆粒球エールリキア菌遺伝子およびその使用 |
| US20030194756A1 (en) * | 2002-04-12 | 2003-10-16 | O'connor Thomas Patrick | Peptides for detection of antibody to Ehrlichia equi |
| US7087372B2 (en) * | 2001-01-18 | 2006-08-08 | Idexx Laboratories, Inc. | Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
| US7407770B2 (en) * | 2001-01-18 | 2008-08-05 | Idexx Corporation | Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
| US20030129680A1 (en) * | 2001-10-31 | 2003-07-10 | O'connor Thomas Patrick | Multi-analyte assay device |
| US7183060B2 (en) * | 2005-02-22 | 2007-02-27 | Idexx Laboratories, Inc. | Peptides for detection of antibody to Ehrlichia ewingii |
| BRPI0706436A2 (pt) * | 2006-01-05 | 2011-03-29 | Medical Instill Tech Inc | válvula unidirecional e aparelho e método de uso da mesma |
| US7507789B2 (en) * | 2007-04-09 | 2009-03-24 | Idexx Laboratories, Inc. | Detection of Anaplasma platys |
| WO2009039413A2 (en) * | 2007-09-21 | 2009-03-26 | Idexx Laboratories, Inc. | Methods and compositions for detection of ehrlichia chaffeensis (p120) |
| US7964366B2 (en) * | 2007-09-21 | 2011-06-21 | Idexx Laboratories, Inc. | Methods and compositions for detection of Ehrlichia chaffeensis (VLPT) |
| WO2009070507A2 (en) | 2007-11-27 | 2009-06-04 | Idexx Laboratories, Inc. | Anaplasma phagocytophilum (aph) antigens and antibodies specific for anaplasma |
| BRPI0920387A2 (pt) | 2008-10-08 | 2014-01-28 | Idexx Lab Inc | Composições e métodos para detecção de anticorpos específicos para anaplasma phagocytophilum (aph) e anaplasma platys (apl) |
| US8828675B2 (en) * | 2009-11-20 | 2014-09-09 | Abaxis, Inc. | Peptides, devices, and methods for the detection of ehrlichia antibodies |
| US10100092B2 (en) | 2011-11-03 | 2018-10-16 | Vca, Inc. | Compositions and methods to detect various infectious organisms |
| WO2013113000A2 (en) | 2012-01-26 | 2013-08-01 | Luc Montagnier | Detection of dna sequences as risk factors for hiv infection |
| US20130236898A1 (en) * | 2012-03-09 | 2013-09-12 | Charles A. Kallick | Anaplasma FAMILY MEMBERS CAUSE A NUMBER OF BLOOD-BORNE DISEASES |
| AU2013329025B2 (en) | 2012-10-11 | 2019-07-04 | Zoetis Services Llc | Peptides, devices, and methods for the detection of Ehrlichia antibodies |
| US9194870B2 (en) | 2014-01-21 | 2015-11-24 | Abaxis, Inc. | Peptides, devices, and methods for the detection of Anaplasma antibodies |
| US9442112B2 (en) | 2014-04-04 | 2016-09-13 | Abaxis, Inc. | Compositions and methods for identifying Ehrlichia species |
| BR112018005825B1 (pt) * | 2015-11-02 | 2022-05-17 | Halliburton Energy Services, Inc | Método e sistema de fraturamento e de embalagem de cascalho |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235877A (en) | 1979-06-27 | 1980-11-25 | Merck & Co., Inc. | Liposome particle containing viral or bacterial antigenic subunit |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
| EP0173494A3 (de) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimäre Rezeptoren durch Verbindung und Expression von DNS |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| AU606320B2 (en) | 1985-11-01 | 1991-02-07 | International Genetic Engineering, Inc. | Modular assembly of antibody genes, antibodies prepared thereby and use |
| US5047540A (en) | 1987-12-17 | 1991-09-10 | Shionogi & Co., Ltd. | Lipid derivatives |
| US6284238B1 (en) | 1995-06-06 | 2001-09-04 | Aquila Biopharmaceuticals, Inc. | Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods |
| US5976860A (en) | 1995-06-06 | 1999-11-02 | Aquila Biopharmaceuticals, Inc. | Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods |
| US6015691A (en) | 1996-05-31 | 2000-01-18 | Research Development Foundation | Immunodominant 120 kDa surface-exposed adhesion protein genes of Ehrlichia chaffeensis |
| WO1998014584A2 (en) * | 1996-10-01 | 1998-04-09 | Yale University | Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis |
| US6207169B1 (en) | 1997-03-21 | 2001-03-27 | Corixa Corporation | Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| US6277381B1 (en) | 1997-03-21 | 2001-08-21 | Corixa Corporation | Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| US6231869B1 (en) | 1997-03-21 | 2001-05-15 | Corixa Corporation | Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| EP0915979A2 (de) | 1997-04-25 | 1999-05-19 | Aquila Biopharmaceuticals, Inc. | Nukleinsäuren, proteine und verfahren zur anwendung von granulozyten-spezifischen ehrlichia |
| ATE438657T1 (de) * | 1997-04-25 | 2009-08-15 | Antigenics Inc | Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung. |
| AU3483599A (en) | 1998-04-09 | 1999-11-01 | Ohio State Research Foundation, The | Nucleic acids encoding outer membrane protein of human granulocytic ehrlichiosisagent |
| JP2002527042A (ja) | 1998-07-28 | 2002-08-27 | アクウィラ・バイオファーマシューティカルズ・インコーポレイテッド | 顆粒球エールリキア菌遺伝子およびその使用 |
| IT1395574B1 (it) | 2009-09-14 | 2012-10-16 | Guala Dispensing Spa | Dispositivo di erogazione |
| BR112012027707A2 (pt) | 2010-04-29 | 2018-05-08 | Dfine Inc | dispositivo médico para tratar tecido rígido |
| JP6649950B2 (ja) | 2014-09-22 | 2020-02-19 | シェフラー テクノロジーズ アー・ゲー ウント コー． カー・ゲーＳｃｈａｅｆｆｌｅｒ Ｔｅｃｈｎｏｌｏｇｉｅｓ ＡＧ ＆ Ｃｏ． ＫＧ | 単一のダンパを備えたハイブリッド駆動モジュール |
-
1998
- 1998-04-24 AT AT98919870T patent/ATE438657T1/de not_active IP Right Cessation
- 1998-04-24 EP EP08006552A patent/EP2060631A3/de not_active Withdrawn
- 1998-04-24 EP EP98919870A patent/EP0915980B1/de not_active Expired - Lifetime
- 1998-04-24 AU AU72563/98A patent/AU7256398A/en not_active Abandoned
- 1998-04-24 EP EP10185020A patent/EP2311957A1/de not_active Ceased
- 1998-04-24 DE DE69841037T patent/DE69841037D1/de not_active Expired - Lifetime
- 1998-04-24 US US09/066,046 patent/US6204252B1/en not_active Expired - Lifetime
- 1998-04-24 WO PCT/US1998/008265 patent/WO1998049313A2/en active Application Filing
- 1998-04-24 ES ES98919870T patent/ES2330393T3/es not_active Expired - Lifetime
- 1998-04-24 CA CA2258277A patent/CA2258277C/en not_active Expired - Lifetime
-
2001
- 2001-02-26 US US09/792,957 patent/US7863434B2/en not_active Expired - Fee Related
-
2010
- 2010-08-18 US US12/859,236 patent/US8093008B2/en not_active Expired - Fee Related
-
2012
- 2012-01-09 US US13/346,088 patent/US8461323B2/en not_active Expired - Fee Related
- 2012-06-25 US US13/532,222 patent/US8435495B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2258277C (en) | 2013-08-13 |
| US20120270232A1 (en) | 2012-10-25 |
| US8093008B2 (en) | 2012-01-10 |
| US20110045605A1 (en) | 2011-02-24 |
| EP2060631A3 (de) | 2009-07-15 |
| US20120178102A1 (en) | 2012-07-12 |
| WO1998049313A3 (en) | 1999-01-14 |
| EP2060631A2 (de) | 2009-05-20 |
| US20100088774A1 (en) | 2010-04-08 |
| US8461323B2 (en) | 2013-06-11 |
| EP0915980B1 (de) | 2009-08-05 |
| US6204252B1 (en) | 2001-03-20 |
| ATE438657T1 (de) | 2009-08-15 |
| US7863434B2 (en) | 2011-01-04 |
| CA2258277A1 (en) | 1998-11-05 |
| US8435495B2 (en) | 2013-05-07 |
| WO1998049313A2 (en) | 1998-11-05 |
| ES2330393T3 (es) | 2009-12-09 |
| EP0915980A2 (de) | 1999-05-19 |
| AU7256398A (en) | 1998-11-24 |
| EP2311957A1 (de) | 2011-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69841037D1 (de) | Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung. | |
| DE69840669D1 (de) | Pca3, pca3-gene und verfahren zu ihrer verwendung | |
| Harper et al. | The purification of nerve growth factor from bovine seminal plasma. Biochemical characterization and partial amino acid sequence. | |
| DK169724B1 (da) | Fremgangsmåde til fremstilling af et polypeptidfragment af faktor VIII:C, DNA-sekvens, som koder herfor, og ekstrachromosomalt element indeholdende en sådan DNA-sekvens | |
| DK0868519T3 (da) | Diagnose og behandling af AUR-1- og/eller AUR-2-relaterede lidelser | |
| DE60140773D1 (de) | Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS) | |
| DE60026332D1 (de) | Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen | |
| ATE209356T1 (de) | Ein verfahren zur bestimmung von kollagenfragmenten in körperflüssigkeiten, ein testkit und mittel zur durchführung des verfahrens, und seine verwendung zur feststellung von mit dem kollagenmetabolismus assoziierten störungen | |
| WO1998057984A3 (en) | Torsin, torsin genes, and methods of use | |
| DE69535921D1 (de) | Alk-7 (aktivin-rezeptor-ähnliche kinase), ein serin/threonin kinase rezeptor | |
| ES2079621T3 (es) | Procedimiento de identificacion o de titulacion de proteinas y aplicaciones. | |
| Brock et al. | Characterization of monoferric fragments obtained by tryptic cleavage of bovine transferrin | |
| ATE350398T1 (de) | Protein s polypeptide und deren verwendungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8328 | Change in the person/name/address of the agent |
Representative=s name: JONES DAY RECHTSANWAELTE PATENTANWAELTE, 80538 MUE |
|
| 8364 | No opposition during term of opposition |